Real-time and programmable transcriptome sequencing with PROFIT-seq

Jinyang Zhang,Lingling Hou,Lianjun Ma,Zhengyi Cai,Shujun Ye,Yang Liu,Peifeng Ji,Zhenqiang Zuo,Fangqing Zhao
DOI: https://doi.org/10.1038/s41556-024-01537-1
IF: 21.3
2024-10-25
Nature Cell Biology
Abstract:The high diversity and complexity of the eukaryotic transcriptome make it difficult to effectively detect specific transcripts of interest. Current targeted RNA sequencing methods often require complex pre-sequencing enrichment steps, which can compromise the comprehensive characterization of the entire transcriptome. Here we describe programmable full-length isoform transcriptome sequencing (PROFIT-seq), a method that enriches target transcripts while maintaining unbiased quantification of the whole transcriptome. PROFIT-seq employs combinatorial reverse transcription to capture polyadenylated, non-polyadenylated and circular RNAs, coupled with a programmable control system that selectively enriches target transcripts during sequencing. This approach achieves over 3-fold increase in effective data yield and reduces the time required for detecting specific pathogens or key mutations by 75%. We applied PROFIT-seq to study colorectal polyp development, revealing the intricate relationship between host immune responses and bacterial infection. PROFIT-seq offers a powerful tool for accurate and efficient sequencing of target transcripts while preserving overall transcriptome quantification, with broad applications in clinical diagnostics and targeted enrichment scenarios.
cell biology
What problem does this paper attempt to address?